Targeting STAT5 in Leukemia Through Inhibition of Bromodomain Proteins

被引:0
|
作者
Liu, Suhu [1 ]
Walker, Sarah [1 ]
Nelson, Erik [1 ]
Cirulli, Robert [1 ]
Xiang, Michael [1 ]
Qi, Jun [1 ]
Bradner, James E. [1 ]
Frank, David [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1182/blood.V120.21.399.399
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
399
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2
    Liu, Suhu
    Walker, Sarah R.
    Nelson, Erik A.
    Cerulli, Robert
    Xiang, Michael
    Toniolo, Patricia A.
    Qi, Jun
    Stone, Richard M.
    Wadleigh, Martha
    Bradner, James E.
    Frank, David A.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (05) : 1194 - 1205
  • [2] The different functions of Stat5 and chromatin alteration through Stat5 proteins
    Kornfeld, Jan-Wilhelm
    Grebien, Florian
    Kerenyi, Marc A.
    Friedbichler, Katrin
    Kovacic, Boris
    Zankl, Barbara
    Hoelbl, Andrea
    Nivarti, Harini
    Beug, Hartmut
    Sexl, Veronika
    Muller, Mathias
    Kenner, Lukas
    Mullner, Ernst W.
    Gouilleux, Fabrice
    Moriggl, Richard
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 6237 - 6254
  • [3] Pharmacologic inhibition of STAT5 in acute myeloid leukemia
    Wingelhofer, Bettina
    Maurer, Barbara
    Heyes, Elizabeth C.
    Cumaraswamy, Abbarna A.
    Berger-Becvar, Angelika
    de Araujo, Elvin D.
    Orlova, Anna
    Freund, Patricia
    Ruge, Frank
    Park, Jisung
    Tin, Gary
    Ahmar, Siawash
    Lardeau, Charles-Hugues
    Sadovnik, Irina
    Bajusz, David
    Keseru, Gyorgy Miklos
    Grebien, Florian
    Kubicek, Stefan
    Valent, Peter
    Gunning, Patrick T.
    Moriggl, Richard
    LEUKEMIA, 2018, 32 (05) : 1135 - 1146
  • [4] Pharmacologic inhibition of STAT5 in acute myeloid leukemia
    Bettina Wingelhofer
    Barbara Maurer
    Elizabeth C. Heyes
    Abbarna A. Cumaraswamy
    Angelika Berger-Becvar
    Elvin D. de Araujo
    Anna Orlova
    Patricia Freund
    Frank Ruge
    Jisung Park
    Gary Tin
    Siawash Ahmar
    Charles-Hugues Lardeau
    Irina Sadovnik
    Dávid Bajusz
    György Miklós Keserű
    Florian Grebien
    Stefan Kubicek
    Peter Valent
    Patrick T. Gunning
    Richard Moriggl
    Leukemia, 2018, 32 : 1135 - 1146
  • [5] Targeting STAT5 in Hematopoietic Malignancies
    Wingelhofer, Bettina
    Heyes, Elizabeth C.
    Lewis, Andrew M.
    Cumaraswamy, Abbarna A.
    Sadovnik, Irina
    Valent, Peter
    Kubicek, Stefan
    Gunning, Patrick T.
    Moriggl, Richard
    CYTOKINE, 2015, 76 (01) : 77 - 77
  • [6] Targeting STAT3 and STAT5 in Cancer
    de Araujo, Elvin D.
    Keseru, Gyorgy M.
    Gunning, Patrick T.
    Moriggl, Richard
    CANCERS, 2020, 12 (08)
  • [7] Stat5 as a diagnostic marker for leukemia
    Lewis, Rowena S.
    Ward, Alister C.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2008, 8 (01) : 73 - 82
  • [8] Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
    Liu, Alex C. H.
    Cathelin, Severine
    Yang, Yitong
    Dai, David L.
    Ayyathan, Dhanoop Manikoth
    Hosseini, Mohsen
    Minden, Mark D.
    Tierens, Anne
    Chan, Steven M.
    CANCER RESEARCH, 2022, 82 (23) : 4325 - 4339
  • [9] STAT5-Interacting Proteins: A Synopsis of Proteins that Regulate STAT5 Activity
    Able, Ashley A.
    Burrell, Jasmine A.
    Stephens, Jacqueline M.
    BIOLOGY-BASEL, 2017, 6 (01):
  • [10] Targeting STAT5 or STAT5-Regulated Pathways Suppresses Leukemogenesis of Ph plus Acute Lymphoblastic Leukemia
    Minieri, Valentina
    De Dominici, Marco
    Porazzi, Patrizia
    Mariani, Samanta A.
    Spinelli, Orietta
    Rambaldi, Alessandro
    Peterson, Luke F.
    Porcu, Pierluigi
    Nevalainen, Marja T.
    Calabretta, Bruno
    CANCER RESEARCH, 2018, 78 (20) : 5793 - 5807